Ligand validation:8SWR

IM5: 2-amino-7-{[(3R,4R)-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-yl]methyl}-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one

IM5 is a Ligand Of Interest in 8SWR designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8SWR_IM5_B_400	57%	52%	0.176	0.953	0.67	1.19	1	2	3	0	100%	0.877
8SWR_IM5_A_400	54%	62%	0.195	0.961	0.78	0.69	1	-	2	0	100%	0.9085
8SWR_IM5_D_400	45%	59%	0.199	0.932	0.76	0.82	1	1	2	0	100%	0.906
8SWS_IM5_B_401	79%	50%	0.115	0.961	0.76	1.15	1	1	0	0	100%	1
4EAR_IM5_C_301	98%	9%	0.052	0.973	2.02	2.36	5	8	0	0	100%	1
5ETJ_IM5_A_301	94%	32%	0.077	0.978	1.07	1.62	1	4	0	0	100%	1
5UGF_IM5_C_305	87%	44%	0.099	0.972	0.85	1.31	-	1	0	0	100%	1
4EB8_IM5_C_302	86%	13%	0.109	0.977	2.14	1.81	4	5	1	0	100%	1
3PHB_IM5_Q_290	85%	35%	0.104	0.968	1.15	1.41	2	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.